© Latvian Institute of Organic Synthesis

Pharmaceutical and biotechnology industries in Latvia have a long history, rich legacy, and extensive know-how. Our talent pool consists of professionals who are passionate about their work and science – many of them are graduates of the world’s best universities.

Top research institutions & partners

  • One of the leading research institutions in the Baltic region and a long-term research partner of pharmaceutical companies in Japan, France, Germany, Switzerland, and the USA. The institute has invented or co-inventor 18 original, approved drugs.

    Research areas:

    • Organic chemistry
    • Medicinal chemistry
    • Physical organic chemistry
    • Pharmacology
  • The leading scientific institute in molecular biology and biomedicine in Latvia.

    Research areas:

    • Human genetics and disease mechanisms
    • Cancer research
    • Structural biology and biotechnology virology
  • One of Latvia’s top-rated universities and the leading academic research institution in the fields of medicine, pharmacy, dentistry, rehabilitation, and nursing sciences.

    Research areas:

    • Oncology
    • Occupational and environmental health
    • Infectious diseases and immunology

Did you know?

World’s first commercial-grade biochips that made it possible to develop original medical diagnostic equipment, such as blood analyzers, were invented by Canada-born Latvian scientist Dr. Imants Lauks.

Latvia’s scientific achievements in biomedicine

Life-changing discoveries and inventions

Virotherapy for cancer

Discovered by Latvian immunologist Aina Muceniece in the 1950s, virotherapy is now a globally recognized treatment for various types of cancer. This innovative treatment uses a virus to find and destroy cancer cells without harming healthy cells.

Rimantadine and mildronate

Two of Latvia's most-exported medications. Mildronate is a cardioprotective drug that is widely used in the treatment of angina and heart failure. Whereas rimantadine is a powerful antiviral, anti-flu, and anti-encephalitis drug; in 2021, it was approved for the treatment of COVID-19 patients as it could help prevent mortality.


Developed by researchers at the Latvian Institute of Organic Synthesis, Belinostat is an active anti-cancer drug. In 2014, it was approved by the U.S. Food and Drug Administration (FDA) for clinical medical use for the treatment of peripheral T-cell lymphoma.

Foundation for Lyme disease vaccine

In 2017, for the first time ever, scientists at the Latvian Biomedical Research & Study Centre calculated the structure of the MS2 virus. This may serve as a basis for the development of a vaccine against Lyme disease, which globally affects nearly 15% of people.

Development of organs-on-a-chip

Teaming up with researchers of the University of Latvia's Laboratory of Micro and Nanodevices and Latvian Biomedical Research and Study Center, biotechnology startup Cellbox Labs is developing organs-on-a-chip – miniature replicas of organs outside the human body. The new technology could help pharmaceutical companies test new drugs more efficiently.